This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (6)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Paul L. Krawitz, MD; Steven M. Podos, MD
New York, NY

Steven M. Podos is a consultant to Alcon Laboratories Inc, Fort Worth, Tex. Neither author has any other commercial or proprietary interest in Alcon or its product, Iopidine.

Arch Ophthalmol. 1990;108(9):1208-1209.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Previous studies have found that apraclonidine is able to blunt the rise in intraocular pressure that follows anterior segment laser procedures. However, to our knowledge, no one to date has reported the efficacy of another possible short-term use of apraclonidine, namely, the treatment of acute angle-closure glaucoma.

Report of a Case.

—A patient was recently examined with a history of elevated intraocular pressures and minimal visual field loss. Her medications included 0.5% levobunolol twice daily in both eyes and 2% pilocarpine four times daily in both eyes, both of which she had used 2 hours prior to examination. Pupil diameters were 2 mm in both eyes. The patient's intraocular pressures were 21 mm Hg in both eyes. By gonioscopic examination, one third to one half of the trabecular meshwork was visible in both eyes with a steep configuration of the peripheral iris and no peripheral anterior synechias. . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?